The FDA has approved IntelGenx/Gensco's rizatriptan benzoate (Rizafilm VersaFilm) oral thin film for acute migraine treatment through the 505(b)(2) new drug application (NDA) pathway
IntelGenx Corp., a Canadian drug delivery company focusing on oral drug delivery, and RedHill Biopharma Ltd. , an Israeli biopharmaceutical...
Acute treatment of the headache phase of migraine attacks with or without aura in adults.
IntelGenx Corp has received a Complete Response Letter from the FDA regarding its resubmitted 505(b)(2) New Drug Application for Rizaport...